Concepedia

Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma

G d’Ancona, Joanne Kavanagh, Cris Roxas, Linda K. Green, Mariana Fernandes, Louise Thomson, Jaideep Dhariwal, Alexandra M. Nanzer, David J. Jackson, Brian D. Kent

European Respiratory Journal · 2020 · 84 citations · 20 references

DOIFull text

Open access

Abstract

ICS nonadherence is common in severe eosinophilic asthma patients receiving mepolizumab, and is associated with a lesser reduction in OCS requirements and AER.

References

20

GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations

, , +6

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung, Sally E. Wenzel, Jan Brożek et al. · European Respiratory Journal · 2013 · 3.8K citations · Full text

, , +15

Development and validation of a questionnaire to measure asthma control

Elizabeth F. Juniper, Paul M. O’Byrne, Gordon Guyatt et al. · European Respiratory Journal · 1999 · 2.5K citations · Full text

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

Héctor Ortega, Mark C. Liu, Ian Pavord et al. · New England Journal of Medicine · 2014 · 2.2K citations · Full text

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Ian Pavord, Stephanie Korn, Peter Howarth et al. · The Lancet · 2012 · 2.2K citations

, , +10